STAT3 and neoplasm: Recently, a comprehensive study in non-small cell lung cancer demonstrated that reduction in STAT3 in the tumor microenvironment using an antisense oligonucleotide reversed immunotherapy resistance in preclinical STK11 knockout mouse models [49].